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As was reported, sleep disorders, excessive daytime sleepiness (EDS) in particular, are 
frequently manifested in epilepsy; insufficient attention has been devoted to this issue in 
clinical practice in Georgia. We investigated the frequency of EDS cases among healthy 
individuals and epilepsy patients. A questionnaire study has been conducted using the 
Epworth Sleepiness Scale (ESS). A group of 251 volunteers (mean age 33.4 years), including 
135 subjects without epilepsy and 116 outpatients with this diagnosis (cryptogenic focal/
idiopathic generalized epilepsy without cognitive or brain abnormalities), completed the 
above questionnaire. The EDS phenomenon was found in 8.9% of healthy individuals and 
in 17.2% of the patients with epilepsy. This problem was more frequent among the epilepsy 
patients treated by antiepileptic drugs (AEDs). The prevalence of EDS was higher among 
men suffering from epilepsy, as compared to women with this disease. In the untreated group 
of the newly diagnosed epilepsy patients, there were more men with EDS than women having 
this problem. The difference in the EDS occurrence between the two groups of outpatients, 
treated and untreated with AEDs, was statistically insignificant. Unlike the individuals 
without epilepsy, a gender difference in terms of the EDS frequency was revealed among the 
newly diagnosed patients. 
Keywords: epilepsy, daytime sleepiness, Georgian population, normalized occurrence, 
gender specificity.
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INTRODUCTION 
Disturbances in the sleep-wake cycle are often 
manifested as daytime sleepiness (DS). Excessive 
DS (EDS) may result from night sleep deprivation 
or fragmentation and can be a significant reason of 
decreased alertness, learning and memory problems, 
and psychomotor impairment [1]. Because EDS is 
associated with a greater risk of motor vehicle and 
work accidents, its assessment is of high importance. 
Excessive DS is a rather common phenomenon, 
occurring in 0.5–5.0% of the general populations [2]. 
Preliminary data on the distribution of sleep-related 
problems in Georgian youth indicated that EDS is 
relatively frequently observed in students living in 
Georgia [3]. This phenomenon is a prominent symptom 
in various psychiatric and neurological diseases [4–
6]. Interrelation of epilepsy and the sleep mode is a 
well-known fact [7, 8]; EDS and sleep disorders are 
frequently manifested in epilepsy [4]. Epilepsy and its 
treatment may dramatically affect sleep organization 
and daytime alertness [9]. Several reports documented 
a high occurrence of clearly manifested EDS cases 
among the epilepsy patients [4, 9–11]. This problem is 
frequently attributed to the treatment with antiepileptic 
drugs (AEDs) [5] and is viewed as an adverse effect 
of the latter [12]. Moreover, it has been reported that 
treatment with AEDs may be a reason for a higher risk 
for sleep disorders in patients with epilepsy; AEDs 
may directly contribute to DS or insomnia or may 
exacerbate underlying sleep disorders [9]. 
According to the epidemiological  research 
conducted in 1987–1991, epilepsy occurred in 0.57% 
of the general population of Georgia [13]. The more 
recent study [14] documented that this rate increased 
up to 0.88%. However, the distribution of DS and/
or other sleep-related problems in patients with or 
without epilepsy has not been studied in Georgia, 
though relatively more attention has been devoted to 
this issue recently [15, 16]. 
Taking into account that recognition of EDS as 
an important medical problem, in particular linked 
with the epilepsy treatment, our study aimed at 
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investigation/evaluation of the EDS occurrence 
among people living in Georgia. This pilot study is 
the first part of a longitudinal research concerning the 
distribution of sleep disorders in epilepsy patients in 
Georgia. 
METHODS
The retrospective study has been carried out in order 
to find associations between epilepsy and EDS. Two 
hundred fifty-one examined subjects (mean age 
33.4 years) were categorized as healthy individuals 
(n = 135, 110 women and 25 men, mean age ± s.d., 
34.6 ± 11.9) and outpatients with epilepsy (n = 116, 
72 women and 44 men, 31.9 ± 12.9 years). The subjects 
with epilepsy were divided into two subgroups, treated 
(T) patients  with AEDs (86 patients, 56 women and 
30 men) and untreated (UT) ones (30 newly diagnosed 
patients, 16 women and 14 men) who have never taken 
AEDs before but suffered from epileptic seizures 
before admission to the Institute of Neurology and 
Neuropsychology (INN, Tbilisi, Georgia). T-group 
patients took various AEDs (carbamazepine, valproate, 
phenobarbital, lamotrigine, or combinational therapy) 
at admission. Epilepsy was diagnosed or the diagnosis 
has been proved according to the international 
classifications [17, 18] based on multidisciplinary 
investigations (consultation of a neurologist/
epileptologist, neuropsychological testing, and EEG 
recordings) at the INN.
Among 116 consecutive epilepsy outpatients, 
95 cases with focal seizures and 21 cases with 
generalized seizures have been identified. All of them 
had normal, in general, cognition and did not have 
any CNS abnormalities on CT/MRI. The subjects 
without epilepsy were in good general health and 
served as controls. The following demographic and 
socioeconomic factors have been considered: age, 
gender, education, marital status, and employment 
(night shift workers were excluded).
All participants were asked to fill out the Epworth 
Sleepiness Scale (ESS) form [19] (following 
appropriate onwards-backwards English-Georgian 
translation), the most frequently used subjective 
evaluation of EDS. The 8-item ESS is widely used as 
a way of measuring subjective sleepiness in research 
and clinical practice [20, 21]. Subjects with the ESS 
score eleven or more were considered as clinically 
significant EDS cases.
Associations for categorical variables were 
examined by the Pearson χ2 test; the Student’s t test 
was used for continuous variables [22]. Data analysis 
was performed using SPSS statistical software, version 
13.0.
RESULTS
A clear association between the diagnosis of epilepsy 
and EDS occurrence was found (χ2 = 3.91, df-1, n = 251, 
P = 0.048). Examination of within-group frequencies 
showed that about 17.2% (20 out of 116) of patients 
with epilepsy experienced EDS, as compared to 8.9% 
(12 out of 135) of individuals without epilepsy, i.e., 
the occurrence of EDS in epilepsy patients was about 
two times greater than that in healthy subjects. 
Among the newly diagnosed patients with epilepsy, 
who have not been treated with AEDs, EDS was 
detected in 13.3% (4 out of 30 cases; the difference 
between EDS frequencies in patients and control 
subjects did not reach the significance level).
A considerable difference was found in the 
prevalence of EDS between UT group-men (28.6%; 
4 out of 14) and healthy men (4.0%; 1 out of 25; 
χ2 = 4.85, df-1, n = 116, P = 0.047). None of the 
women in the UT group had EDS; however, this 
problem was found in 10% (11 out of 110) of women 
without epilepsy.
Considerable intergender differences were observed 
in the frequency of EDS in epilepsy patients. The 
prevalence of EDS was much higher in men (27.3%; 
12 out of 44) than in women (8.3%; 6 out of 72; 
χ2=7.50, df-1, n = 116, P = 0.006 4). As was mentioned, 
in subjects without epilepsy, 10.0% women (11 out of 
110) and 4.0% men (1 out of 25) had EDS; however, 
the difference was statistically insignificant. Four out 
of 30 untreated epilepsy patients (13.3%) and 18 out of 
86 patients treated with AEDs (18.6%) were identified 
as the individuals having EDS; however, the difference 
between these two subgroups was not statistically 
significant.
In the T group, EDS was revealed in 26.7% (8 out 
of 30) of men and 10.7% (6 out of 56) of women 
(the gender difference did not reach the significance 
level). There was a nearly similar distribution of 
EDS in treated and untreated men suffering from 
epilepsy, 26.7% (8 out of 30) and 28.6% (4 out of 14), 
respectively.
NEUROPHYSIOLOGY / НЕЙРОФИЗИОЛОГИЯ.—2015.—T. 47, № 6 561
DAYTIME SLEEPINESS AND EPILEPSY
DISCUSSION
In this pilot study, we have evaluated the EDS 
frequency among the healthy individuals and 
patients with epilepsy living in Georgia, using the 
ESS [19]. This questionnaire has been proposed as 
a quick, efficient, and inexpensive measure of the 
subjective EDS; it is often used for confirmation of 
EDS in epilepsy patients [4, 10]. We found that EDS 
(identified according to ESS score >10) is about two 
times more frequent in epilepsy patients than in the 
individuals free from this pathology. A variety of 
reasons can result in EDS in healthy subjects; yet, a 
much greater occurrence of EDS in epilepsy patients 
shows that this disease clearly correlates with the 
analyzed phenomena. Although EDS was less frequent 
among the subjects without epilepsy, as compared to 
the newly diagnosed untreated epilepsy patients (not 
taking AEDs), this difference was not statistically 
significant. This fact might be related to the relatively 
small number of the newly diagnosed and examined 
untreated epilepsy patients, who applied to the INN in 
the course of our investigation. 
It is often reported that EDS in epilepsy patients 
is due to the treatment by AEDs, and these patients 
possess a higher risk for sleep disorders, as the 
treatment with these drugs may directly contribute to 
DS or insomnia [23, 24]. Using the ESS, a widely used 
and validated subjective measure of DS [19], Malow et 
al [4] reported that 28% of 158 surveyed adult epilepsy 
patients had an elevated score (higher than 10 points). 
The results of our study agree to a certain extent with 
the findings of those authors who have indicated a high 
prevalence of sleep complaints and EDS in epilepsy 
patients [4, 10, 11]. Thus, this phenomenon in epilepsy 
is observed in different countries and among different 
ethnic groups.
Epilepsy outpatients in Georgia, who took AEDs, 
were more predisposed to EDS than the subjects 
without epilepsy. Subjective sleepiness was common 
in both groups (UT and T) of epilepsy patients, but 
only a slight trend toward elevated frequency of EDS 
was revealed among the patients treated with AEDs.
The results of our study concerning intergender 
differences in the prevalence of EDS seem to be 
especially interesting. In particular, it was noted 
that EDS was more frequent in men than in women 
suffering from epilepsy (P < 0.05). No significant 
difference has been observed in the EDS occurrence 
among the healthy men and women. However, more 
than one quarter of male subjects in the UT group 
(taking no AEDs) were identified as having EDS. The 
analysis of the data on the EDS distribution among the 
T group-subjects did not show any gender difference. 
Our findings on the frequency of EDS in men allow 
us to state that EDS was less prevalent among men in 
the control group than among male subjects in the UT 
or T subgroups (P < 0.05). As for the occurrence of 
EDS among women, no intergroup differences have 
been found. An interesting finding was that EDS was 
noticeably more frequent in men compared to women 
in all investigated groups (control, T, and UT).
Thus, the findings of our study on the occurrence 
of EDS among Georgian people with and without 
epilepsy allow us to conclude that EDS is a noticeable 
medical problem in Georgian epilepsy patients. More 
research is needed to assess the EDS occurrence 
among epilepsy patients in relation to the treatment 
strategy, socio-demographic factors, and a sleep-wake 
schedule or sleep difficulties. Longitudinal studies 
have to be carried out to investigate this problem that 
would allow us to clarify whether EDS is a specific 
consequence of anti-epileptic therapy, or sleep 
disorders (insomnia, obstructive sleep apnea, a restless 
legs-syndrome, etc.) frequently coexist with epilepsy 
with no dependence on the treatment used.
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Р е з ю м е
Як відомо, розлади сну, зокрема сонливість вдень, часто ви-
являються при захворюванні на епілепсію; цьому аспекту, 
проте, приділялося недостатньо уваги. Ми визначали час-
тоту випадків надмірної сонливості вдень (НСВ) у здоро-
вих осіб та пацієнтів із епілепсією в Грузії. Дослідження 
було проведено за допомогою опитування з використанням 
Епворт-шкали сонливості (ESS). Група з 251 добровольця 
(середній вік 33.4 року), в котру входили 135 контрольних, 
не хворих на епілепсію осіб, та 116 пацієнтів із діагносто-
ваною криптогенною фокальною/ідіопатичною генералізо-
ваною епілепсією без когнітивних розладів та церебральних 
анормальностей, заповнювали опитувальник ESS. Феномен 
НСВ був виявлений у 8.9 % здорових осіб та 17.2 % паці-
єнтів із епілепсією. Ця проблема зустрічалася частіше се-
ред пацієнтів, що приймали антиепілептичні фармакологіч-
ні засоби. Частота випадків НСВ у чоловіків, що страждали 
на епілепсію, була вищою, ніж така у жінок із подібною 
патологією. У підгрупі пацієнтів із щойно встановленим 
діагнозом, котрі не піддавалися антиепілептичній терапії, 
нормована кількість чоловіків із НСВ була вищою, ніж ана-
логічний показник у жінок. Різниця частот НСВ у двох під-
групах пацієнтів, котрі приймали або не приймали антиепі-
лептичні засоби, була статистично невірогідною. На відміну 
від групи контролю, у пацієнтів зі щойно встановленим ді-
агнозом спостерігалася залежність частоти НСВ від статі. 
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